DK8591D0 - Interleukin-l inhibotor - Google Patents

Interleukin-l inhibotor

Info

Publication number
DK8591D0
DK8591D0 DK008591A DK8591A DK8591D0 DK 8591 D0 DK8591 D0 DK 8591D0 DK 008591 A DK008591 A DK 008591A DK 8591 A DK8591 A DK 8591A DK 8591 D0 DK8591 D0 DK 8591D0
Authority
DK
Denmark
Prior art keywords
inhibotor
interleukin
Prior art date
Application number
DK008591A
Other languages
English (en)
Other versions
DK8591A (da
DK172763B1 (da
Inventor
Charles H Hannum
Stephen P Eisenberg
Robert C Thompson
William P Arend
Fenneke G Joslin
Andreas Sommer
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Inc filed Critical Synergen Inc
Publication of DK8591A publication Critical patent/DK8591A/da
Publication of DK8591D0 publication Critical patent/DK8591D0/da
Application granted granted Critical
Publication of DK172763B1 publication Critical patent/DK172763B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK199100085A 1988-05-27 1991-01-18 Isoleret interleukin-1 (IL-1) inhibitor eller forstadiepolypeptid dertil, isoleret DNA-molekyle, som koder derfor, vektor o DK172763B1 (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US19991588A 1988-05-27 1988-05-27
US19991588 1988-05-27
US23871388A 1988-08-31 1988-08-31
US23871388 1988-08-31
US26653188A 1988-11-03 1988-11-03
US26653188 1988-11-03
PCT/US1989/002275 WO1989011540A1 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors
US8902275 1989-05-25

Publications (3)

Publication Number Publication Date
DK8591A DK8591A (da) 1991-01-18
DK8591D0 true DK8591D0 (da) 1991-01-18
DK172763B1 DK172763B1 (da) 1999-07-05

Family

ID=27394086

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199100085A DK172763B1 (da) 1988-05-27 1991-01-18 Isoleret interleukin-1 (IL-1) inhibitor eller forstadiepolypeptid dertil, isoleret DNA-molekyle, som koder derfor, vektor o

Country Status (9)

Country Link
JP (2) JP3192651B2 (da)
KR (1) KR970002917B1 (da)
BR (1) BR8907457A (da)
DK (1) DK172763B1 (da)
FI (2) FI109206B (da)
HU (3) HU9803037D0 (da)
NO (2) NO316122B1 (da)
OA (1) OA09631A (da)
WO (1) WO1989011540A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
JPH05506986A (ja) * 1990-05-01 1993-10-14 カイロン　コーポレイション インターロイキン―１拮抗物質及びその利用
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
US5747444A (en) * 1990-10-09 1998-05-05 Chiron Corporation Method of treating graft-versus-host disease
US5932537A (en) * 1990-10-09 1999-08-03 Chiron Corporation Method for attenuating a cellular response to IL-1
ZA921120B (en) 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US20030103978A1 (en) 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
TR201809678T4 (tr) 2001-06-26 2018-07-23 Amgen Fremont Inc Opgl ye karşi antikorlar.
WO2003035048A2 (en) * 2001-10-26 2003-05-01 Novartis Ag Methods for the treatment of osteoarthritis and compositions thereof
AU2003243139B2 (en) 2002-04-05 2007-06-21 Amgen Inc. Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
ES2414460T3 (es) 2004-08-04 2013-07-19 Amgen Inc. Anticuerpos para Dkk-1
JP5718640B2 (ja) 2007-08-21 2015-05-13 アムジエン・インコーポレーテツド ヒトｃ−ｆｍｓ抗原結合性タンパク質
JP5976319B2 (ja) * 2008-09-12 2016-08-23 エックスバイオテク, インコーポレイテッドXbiotech, Inc. 病原性単球の標的化
WO2012025910A1 (en) 2010-08-26 2012-03-01 Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional METHODS OF DIAGNOSIS AND TREATMENT OF OSTEOARTHRITIS AT EARLY STAGES USING INTERLEUKIN IL-1ß AS EARLY BIOMARKER OF THE DISEASE
EP2686431B1 (en) 2011-03-14 2016-08-03 Phlogo ApS Antagonists of the interleukin- 1 receptor
WO2012142391A1 (en) 2011-04-15 2012-10-18 Merck Patemt Gmbh Anti- il-1r1 inhibitors for use in cancer
TW201605896A (zh) 2013-08-30 2016-02-16 安美基股份有限公司 Gitr抗原結合蛋白
WO2015087187A1 (en) 2013-12-10 2015-06-18 Rinat Neuroscience Corp. Anti-sclerostin antibodies
MX2018010851A (es) 2016-03-08 2019-02-07 Janssen Biotech Inc Anticuerpos de gitr, métodos, y usos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3014099B2 (ja) * 1987-08-26 2000-02-28 バイオジェン インコーポレイテッド 生物的材料、生物的材料の生産およびこの種の材料の治療への使用方法

Also Published As

Publication number Publication date
JP2001029093A (ja) 2001-02-06
FI20020545L (fi) 2002-03-21
NO316917B1 (no) 2004-06-21
NO20014783L (no) 1991-01-28
DK8591A (da) 1991-01-18
NO905090L (no) 1991-01-28
HU9803037D0 (en) 1999-11-29
HU222810B1 (hu) 2003-11-28
FI20020545A7 (fi) 2002-03-21
AU633831B2 (en) 1993-02-11
WO1989011540A1 (en) 1989-11-30
BR8907457A (pt) 1991-04-02
NO905090D0 (no) 1990-11-23
NO316122B1 (no) 2003-12-15
HU215434B (hu) 1999-04-28
NO20014783D0 (no) 2001-10-01
FI109206B (fi) 2002-06-14
HU893412D0 (en) 1991-05-28
DK172763B1 (da) 1999-07-05
AU3746989A (en) 1989-12-12
JP3192651B2 (ja) 2001-07-30
JPH03505279A (ja) 1991-11-21
KR970002917B1 (ko) 1997-03-12
OA09631A (en) 1993-04-30
FI905812A0 (fi) 1990-11-26

Similar Documents

Publication Publication Date Title
FR2632154B1 (fr) Moissonneuse
DK233989D0 (da) Mejetaerskerskaerebord
DK666589A (da) D-vitamin homologer
FR2635277B1 (fr) Vibrocrible
DK8591A (da) Interleukin-l inhibitor
DK184489D0 (da) Bicyclodioner
FI893294A0 (fi) Paperinliimauskoostumuksia
IT8922733A0 (it) Suscettore
FI896361A0 (fi) Väliainepainetoimimoottori
NO176729C (no) Brönnrömmer
DK386089A (da) Katekolderivater
DK137889D0 (da) Foldeaeske
KR900701692A (ko) 피라졸로-피롤로-피리미딘-디온
DK6190D0 (da) Cyklonseparatorapparat
DK318789D0 (da) Mitomycin-n7-alkylfosfatderivater
DK182290D0 (da) Foldeaeske
DK100890D0 (da) Spjaeldregulerende arrangement
DK165575C (da) Loeftesele
DE68926367D1 (de) Hydroxymethylcyclobutylpurine
DK565189A (da) Naphthalenderivater
DK453289A (da) Diuresefaktor
DK536788D0 (da) Foldeaeske
FI896126A7 (fi) Kulmanmittain
IT8803202V0 (it) Reintpress
FI954856A7 (fi) 13-alkyyli-11beta-fenyyligonaanit

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
AGE Re-establishment of rights: approved
B1 Patent granted (law 1993)
PUP Patent expired